LATHAM, N.Y.--(BUSINESS WIRE)--
AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative,
minimally invasive medical devices for vascular access, peripheral
vascular disease, surgery and oncology, today announced that it will
present at the following two investor conferences in May:
Conference: Deutsche Bank 43rd Annual Healthcare Conference
Date: Tuesday, May 8, 2018
Presentation: 3:30 p.m.
Speakers: Jim Clemmer, President and Chief Executive Officer,
and Michael C. Greiner, Executive Vice President and Chief Financial
Conference: UBS Global Healthcare Conference
Location: New York, NY
Monday, May 21, 2018
Presentation: 9:00 a.m. ET
Clemmer, President and Chief Executive Officer
A live webcast of each presentation will be accessible through the
"Investors" section of the Company's website at www.angiodynamics.com
and will be available for replay following each event.
About AngioDynamics, Inc.
AngioDynamics, Inc. is a leading provider of innovative, minimally
invasive medical devices used by professional healthcare providers for
vascular access, surgery, peripheral vascular disease and oncology.
AngioDynamics' diverse product lines include market-leading ablation
systems, fluid management systems, vascular access products,
angiographic products and accessories drainage products, thrombolytic
products and venous products. For more information, visit www.angiodynamics.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180410006393/en/
Michael C. Greiner, 518-795-1821
Vice President & CFO
Source: AngioDynamics, Inc.
News Provided by Acquire Media